4,200
edits
Catecholaminergic Polymorphic Ventricular Tachycardia: Difference between revisions
Catecholaminergic Polymorphic Ventricular Tachycardia (view source)
Revision as of 13:16, 26 July 2007
, 26 July 2007no edit summary
mNo edit summary |
mNo edit summary |
||
| Line 21: | Line 21: | ||
** the CASQ2 gene, coding for the calsequestrine protein: ([[w:OMIM|OMIM™]] link {{OMIM2|114251}}) (1-2 % of patients) | ** the CASQ2 gene, coding for the calsequestrine protein: ([[w:OMIM|OMIM™]] link {{OMIM2|114251}}) (1-2 % of patients) | ||
'''Treatment''' | '''Treatment'''<cite>ACC2006</cite> | ||
* Beta-blockers | * Beta-blockers | ||
* [[w:nl:Internal_Cardiac_Defibrillator|ICD]] implantation combined with beta-blockers in CPVT patients who survived a cardiac arrest.<cite>sumitomo</cite> | * [[w:nl:Internal_Cardiac_Defibrillator|ICD]] implantation combined with beta-blockers in CPVT patients who survived a cardiac arrest.<cite>sumitomo</cite> | ||